These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3785587)

  • 1. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T; Hagino Y
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice.
    Moroji T; Hagino Y
    Neuropeptides; 1987 Apr; 9(3):217-24. PubMed ID: 3601011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
    Hagino Y; Moroji T; Iizuka R
    Neuropeptides; 1989; 13(2):107-13. PubMed ID: 2739882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
    Zetler G
    Neuropharmacology; 1985 Mar; 24(3):251-9. PubMed ID: 2859544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM; Gaffori O; De Wied D
    Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G
    Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of ceruletide in the vertical and horizontal locomotor activities of mice.
    Itoh T; Murai S; Masuda Y; Abe E; Ohkubo N; Itsukaichi O; Shoji S
    Pharmacol Biochem Behav; 1992 Oct; 43(2):571-6. PubMed ID: 1438494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine separates the antinociceptive effects of cholecystokinin octapeptide and ceruletide from those of morphine.
    Zetler G
    Eur J Pharmacol; 1983 Aug; 92(1-2):151-4. PubMed ID: 6313385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central effects of ceruletide analogues.
    Zetler G
    Peptides; 1981; 2 Suppl 2():65-9. PubMed ID: 6283499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of cholecystokinin and its related peptides in rats.
    Itoh S; Katsuura G
    Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
    Vasar E; Harro J; Lang A; Pôld A; Soosaar A
    Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
    Zetler G
    Eur J Pharmacol; 1984 Jul; 102(2):333-40. PubMed ID: 6090162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
    Kihara T; Ikeda M; Matsubara K; Matsushita A
    Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
    Zetler G
    Eur J Pharmacol; 1985 May; 111(3):309-18. PubMed ID: 2862047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
    Hsiao S; Katsuura G; Itoh S
    Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceruletide acts in the abdomen, not in the brain, to produce satiety.
    Smith GP; Jerome C; Kulkosky P; Simansky KJ
    Peptides; 1984; 5(6):1149-57. PubMed ID: 6099563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.